✨ Unlock Data Exports And Disclosure Access. Start Your 30-Day Free Trial Today →

Innovent Biologics Inc

Common Name
Innovent Biologics
Country
China (Mainland)
Sector
Healthcare
Industry
Biotechnology
Employees
6,190
Ticker
1801
Exchange
HONG KONG EXCHANGES AND CLEARING LTD
Description
Innovent Biologics Inc. engages in the research, development, manufacture, and sale of biologic therapies, primarily focusing on oncology, autoimmune, metabolic, and other major diseases. As a pharmac...

Disclosures of Innovent Biologics

Explore Innovent Biologics's complete collection of publicly available corporate disclosures, including annual reports, sustainability reports, financial statements, ESG data spreadsheets, and related web publications. Each document is sourced directly from Innovent Biologics's official channels and fully traceable to its official company sources.

The table below lists all of Innovent Biologics's' corporate disclosure by name and reporting period, ensuring full transparency and easy access.

If you want to search across Innovent Biologics's' disclosures for specific data or insights, use our Disclosure Search.

NameReporting Period
Annual Report
2024
ESG Report
2024
ESG Report
2023
Annual Report
2023
ESG Report
2022
Annual Report
2022
Financial & Extra-Financial Disclosure
2021
ESG Report
2021
Annual Report
2021
ESG Report
2020
Financial & Extra-Financial Disclosure
2020
Annual Report
2020
ESG Report
2019
Annual Report
2019
Financial & Extra-Financial Disclosure
2019
Financial & Extra-Financial Disclosure
2018
Annual Report
2018
ESG Report
2018
Real-Time Disclosures Datafeed

Get Notified Within Seconds of New Corporate Disclosures

Tracenable is building a high-speed disclosure monitoring system that delivers instant alerts when companies publish new reports or data. Could a real-time datafeed (via SFTP, RSS or API) enhance your investment or analytical workflows?